MAPT and Alzheimer disease: Next, we confirmed that R1, Tau7, NT9, and NT15 antibodies are not impacted by the phosphorylation status of tau proteins using temporal lobe cortical sections from a neuropathologically confirmed Alzheimer’s disease patient.